Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Canada
Deutschland
España
France
Italia
Schweiz (DE)
Suisse (FR)
United Kingdom
United States
Settings
Dynamic quotes
OFF
ON
Markets
Equities
North America
Europe
Asia
Oceania
Middle East
»
More Equities
Indexes
DOW JONES
S&P 500
NASDAQ 100
TSX COMP
NIKKEI 225
»
More Indexes
Currency / Forex
EUR / USD
GBP / USD
USD / JPY
USD / CAD
AUD / USD
»
More Currencies
Commodities
GOLD
Crude Oil (WTI)
Crude Oil (BRENT)
SILVER
PLATINUM
»
More Commodities
Trackers & ETF
Rankings and News
Advanced Search
Cryptocurrencies
BITCOIN
ETHEREUM
News
Latest News
Companies
Markets
Economy
Currency / Forex
Commodities
Interest Rates
Business Leaders
Cryptocurrencies
Cybersecurity
Economic calendar
Listed companies
Analyst reco.
Rumors
IPOs
Capital Markets Transactions
New Contracts
Profit warnings
Appointments
Press Releases
Events
Corporate actions
Financial calendar
Sector News
Energy
Basic Materials
Industrials
Consumer Cyclical
Consumer Non-Cyclical
Financials
Healthcare
Technology
Telecommunications Services
Utilities
Analysis
All Analysis
Must Read
Daily briefing
Weekly market update
Stock Trading Strategies
Stock Picks
All stock picks
Subscribe
Portfolios
My Portfolio
Virtual portfolios
MarketScreener Portfolios
USA Portfolio
European Portfolio
Asian Portfolio
Watchlists
My Watchlists
Watchlists
My previous session
My most visited
Most popular
Investment style
Yield stocks
Growth stocks
Undervalued Stocks
Investment themes
Water
Sin stocks
Biotechnology
At the foot of the Mont Blanc
Place your bets
Europe's family businesses
Let’s all cycle!
Fintechs
Ageing Population
Top / Flop
Top News
Most Read News
Hot News
Top Fundamentals
Top Capitalization
Top Yield
Top PER
Top Consensus
Top Fundamentals
Top Technicals
Top RSI
Unusual volumes
Top Gaps
Top STIM
Breakouts
Trends
Top Movers
Top USA
Top Canada
Top U.K.
Top Germany
Top Europe
Top Asia
Screeners
Investment selections
Water
Sin stocks
Biotechnology
At the foot of the Mont Blanc
Place your bets
Europe's family businesses
Technical Rankings
Oversold stocks
Overbought stocks
Close to resistance
Close to support
Accumulation Phases
Most volatile stocks
Fundamental Rankings
Top Investor Rating
Top Trading Rating
Top Consensus
Growth stocks
Yield stocks
Low valuations
Stock Screener Home
My Screeners
All my stocks
Watchlists
Virtual Portfolios
Tools
MarketScreener tools
Stock Screener
iPhone App
Expert tools
Stock Screener PRO
Portfolio Creator
Event Screener
Dynamic chart
Financial calendar
Economic calendar
Sector research
Currency converter
ProRealTime Trading
Our Services
MarketScreener Portfolios
European Portfolio
USA Portfolio
Asian Portfolio
Our Stock Picks
Thematic Investment Lists
Stock Screener
MarketScreener Homepage
>
Equities
>
Nasdaq
>
Ariad Pharmaceuticals, Inc.
ARIAD PHARMACEUTICALS, INC.
Add to my list
No quotes available
--
USD
--.--%
2017
ARIAD PHARMACEUTICALS
: Announces Submission of Marketing Authorization Application for Brigatinib to the European Medicines Agency
BU
2017
ARIAD PHARMACEUTICALS
: Enters into Definitive Agreement to Be Acquired by Takeda for $5.2 Billion
PU
2017
ARIAD PHARMACEUTICALS
: Takeda to Acquire ARIAD Pharmaceuticals, Inc.
PU
Summary
News
Company
Summary
Most relevant
All News
Analyst Reco.
Other languages
Press Releases
Official Publications
Sector news
Most relevant news about ARIAD PHARMACEUTICALS, INC.
2017
ARIAD PHARMACEUTICALS
: Announces Submission of Marketing Authorization Applicat..
BU
2017
ARIAD PHARMACEUTICALS
: Enters into Definitive Agreement to Be Acquired by Taked..
PU
2017
ARIAD PHARMACEUTICALS
: Takeda to Acquire ARIAD Pharmaceuticals, Inc.
PU
2017
ARIAD PHARMACEUTICALS
: Acquisition May Not Be in the Best Interests of ARIA Sha..
PR
2017
ARIAD SHAREHOLDER NOTICE
: Faruqi & Faruqi, LLP Announces the Investigation of A..
PR
2017
Brower Piven Commences An Investigation Into The Proposed Sale Of ARIAD Pharm..
BU
2017
HARWOOD FEFFER LLP
: Announces Investigation of ARIAD Pharmaceuticals, Inc.
PR
2017
ARIAD PHARMACEUTICALS, INC. Rigrodsky & Long, P.A. Announces Investigation Of..
BU
2017
ARIAD PHARMACEUTICALS
: Enters into Definitive Agreement to Be Acquired by Taked..
BU
2017
ARIAD PHARMACEUTICALS
: Takeda to Acquire ARIAD Pharmaceuticals, Inc.
BU
2017
ARIAD PHARMACEUTICALS
: to Present at the 35th Annual J.P. Morgan Healthcare Con..
BU
2016
ARIAD PHARMACEUTICALS
: Investigational Medicine Brigatinib Demonstrated 15.6 Mo..
BU
2016
ARIAD PHARMACEUTICALS
: Announces Data Presentations at American Society of Hema..
BU
2016
ARIAD PHARMACEUTICALS
: Presents Updated Brigatinib Data with 18.4 Months Median..
BU
2016
ARIAD PHARMACEUTICALS
: to Host Webcast and Conference Call on Brigatinib Data P..
BU
More most relevant news
All news about ARIAD PHARMACEUTICALS, INC.
2017
ARIAD PHARMACEUTICALS
: Announces Submission of Marketing Authorization Applicat..
BU
2017
ARIAD PHARMACEUTICALS
: Enters into Definitive Agreement to Be Acquired by Taked..
PU
2017
ARIAD PHARMACEUTICALS
: Takeda to Acquire ARIAD Pharmaceuticals, Inc.
PU
2017
ARIAD PHARMACEUTICALS
: Acquisition May Not Be in the Best Interests of ARIA Sha..
PR
2017
ARIAD SHAREHOLDER NOTICE
: Faruqi & Faruqi, LLP Announces the Investigation of A..
PR
2017
Brower Piven Commences An Investigation Into The Proposed Sale Of ARIAD Pharm..
BU
2017
Japan's Takeda ready for fresh acquisitions after $5.2 billion Ariad deal
RE
2017
HARWOOD FEFFER LLP
: Announces Investigation of ARIAD Pharmaceuticals, Inc.
PR
2017
ARIAD PHARMACEUTICALS, INC. Rigrodsky & Long, P.A. Announces Investigation Of..
BU
2017
ARIAD PHARMACEUTICALS
: Enters into Definitive Agreement to Be Acquired by Taked..
BU
More news
News in other languages on ARIAD PHARMACEUTICALS, INC.
2017
Takeda rachète l'américain Ariad pour 5,2 milliards de dollars
2016
ARIAD PHARMACEUTICALS
: Incyte et ARIAD annoncent un accord dans le cadre duquel..
2016
ARIAD PHARMACEUTICALS
: Incyte und ARIAD geben Vereinbarung zur Übernahme des eu..
2015
ARIAD PHARMACEUTICALS
: annonce le début de l'essai randomisé de phase III OPTIC..
2015
ARIAD PHARMACEUTICALS
: meldet Start der randomisierten Phase-3-Studie OPTIC-2L ..
2015
WALL STREET STOCK EXCHANGE
: Wall Street marque une pause après une semaine erra..
2015
WALL STREET STOCK EXCHANGE
: Wall Street marque une pause après une semaine erra..
2015
Le laboratoire Baxalta serait en négociation pour racheter Ariad
2015
ARIAD PHARMACEUTICALS
: met à jour les données de tolérance et d'efficacité à lo..
2015
ARIAD PHARMACEUTICALS
: legt langfristige Sicherheits- und Wirksamkeitsdaten zu ..
More news
Analyst Recommendations on ARIAD PHARMACEUTICALS, INC.
2017
Japan's Takeda ready for fresh acquisitions after $5.2 billion Ariad deal
RE
2012
New Amgen CEO must win investors with payouts, deals
RE
More recommendations
Press releases
2017
ARIAD PHARMACEUTICALS
: Announces Submission of Marketing Authorization Applicat..
BU
2017
ARIAD PHARMACEUTICALS
: Enters into Definitive Agreement to Be Acquired by Taked..
PU
2017
ARIAD PHARMACEUTICALS
: Takeda to Acquire ARIAD Pharmaceuticals, Inc.
PU
2017
ARIAD PHARMACEUTICALS
: Acquisition May Not Be in the Best Interests of ARIA Sha..
PR
2017
ARIAD SHAREHOLDER NOTICE
: Faruqi & Faruqi, LLP Announces the Investigation of A..
PR
More press releases
Upcoming sector events
01/27/21
LONZA GROUP LTD
: FY 2020 Earnings Release
02/01/21
VERTEX PHARMACEUTICALS INCORPORATED
: FY 2020 Earnings Release
02/02/21
BIO-TECHNE CORPORATION
: Interim 2021 Earnings Release
02/03/21
QIAGEN N.V.
: FY 2020 Earnings Release (Projected)
More events
Sector
Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs
Slave